PATENT CLAIM ANALYSIS

Application Number: 16066402
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["549", "049000"]

Abstract:
The present invention relates to quinolin-2(1H)-one derivatives polymorph and its process thereof. Formula (I).

Claim (Index 24):
The process according to  claim 21 , a process for the preparation of Brexpiprazole compound of Formula I, which comprises: a. reacting the compound of formula XI, wherein X is a leaving group with piperazine compound of formula XII, to obtain a compound of formula XIII; b. treating the compound of formula XIII with anhydrous hydrogen chloride to yield a compound of formula IV; c. optionally desalifying compound of formula IV; d. condensing the compound of formula IV obtained as in step (b) or step (c) with formula III, wherein X is a leaving group to yield a compound of formula I; e. converting Brexpiprazole compound of formula I to Brexpiprazole hydrochloride; f. isolating Brexpiprazole hydrochloride Form H of claim  1 ; and g. converting Brexpiprazole hydrochloride Form H to Brexpiprazole. wherein steps e to g are optional.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 94.0
- Lexical Diversity: 1.15789
- Patent Class: 549.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14373163', '15764616', '15541568', '13995786', '10553399']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7096524063139704
- 35 USC 102 Novelty (BERT): 0.5088449260455147
- Combined Prediction Score: 0.689571658287125
- Mean Citation Score: 237.167226
- Max Citation Score: 244.66219
- Similarity Product: 172.77674996490657

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test